Nature Communications (Nov 2018)
Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems
Abstract
The side effects of cancer drugs limit their utility. Here, the authors developed a method in which an inactive (prodrug) version of the cancer drug doxorubicin enters tumour cells and then gets activated inside the cells upon a trigger facilitated by enzyme-instructed supramolecular self-assembly.